Conference Call

December 06, 2021 | Investor

The management of Bavarian Nordic hosted a conference call on December 6 to present the plans for the RSV vaccine, along with a presentation of the Phase 2 results for the COVID-19 vaccine, followed by a Q&A session.

A replay version of the call and relevant slides can be accessed via the link below.